Development and evaluation of mosapride citrate orally disintegrating tablets for dogs

Development and evaluation of orally disintegrating tablets of Pramipexole using full factorial design

Pramipexole is the mostly prescribed drug in patients with Parkinson disease. The incidence of Parkinson disease is related to aging and mostly developed in elderly people with difficulty in swallowing or dysphagia. In the current study we aimed to develop an orally fast disintegrating tablet (ODT) of pramipexole as a preferable alternative in geriatric patients. Hence, the fast disintegration ...

Risperidone Orally Disintegrating Tablets

---------------------------------------------------RECENT MAJOR CHANGES-------------------------------------------------­ Indications and Usage, Schizophrenia/Adolescents (1.1) 08/2007 Indications and Usage, Bipolar Mania/Pediatrics (1.2) 08/2007 Dosage and Administration, Schizophrenia/Adolescents (2.1) 08/2007 Dosage and Administration, Bipolar Mania/Pediatrics (2.2) 08/2007 -----------------...

Formulation of New Sildenafil Citrate-caffeine Orally Disintegrating Tablets: in Vitro and in Vivo Evaluation

Orally Disintegrating Tablets: An Overview

Article history: Received on: 06/01/2014 Revised on: 22/01/2014 Accepted on: 12/02/2014 Available online: 27/02/2014 Orally disintegrating tablets (ODTs) have greatly increased dosage forms which have remarkable impact on the patient compliance especially for the pediatric, geriatric and psychiatric patients with deglutition disorders. Several technologies either conventional or patented based ...

Formulation and Evaluation of Orally Disintegrating Tablets of Rosuvastatin

Rosuvastatin is a Dyslipidaemic Agents, which acts by inhibition of HMG-CoA reductase enzyme. Used in the treatment of hyperlipidemia. Therefore the present investigation was to design a formulation of orally disintegrating tablets of Rosuvastatin. Orally disintegrating tablets of Rosuvastatin were formulated by Superdisintegrant addition method by direct compression technique. All the fourteen...